Compare SYK & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYK | ELV |
|---|---|---|
| Founded | 1941 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.4B | 85.7B |
| IPO Year | 1994 | 2001 |
| Metric | SYK | ELV |
|---|---|---|
| Price | $314.40 | $384.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 19 |
| Target Price | ★ $415.57 | $383.56 |
| AVG Volume (30 Days) | ★ 2.4M | 1.5M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | 1.12% | ★ 1.83% |
| EPS Growth | ★ 8.25 | N/A |
| EPS | 1.93 | ★ 8.00 |
| Revenue | $25,116,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $9.80 | N/A |
| Revenue Next Year | $8.44 | $3.07 |
| P/E Ratio | $160.60 | ★ $49.39 |
| Revenue Growth | 11.16 | ★ 12.49 |
| 52 Week Low | $281.00 | $273.71 |
| 52 Week High | $404.87 | $426.98 |
| Indicator | SYK | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 44.37 |
| Support Level | $290.96 | $307.76 |
| Resistance Level | $319.17 | $408.00 |
| Average True Range (ATR) | 8.18 | 11.00 |
| MACD | 1.10 | -3.91 |
| Stochastic Oscillator | 73.33 | 5.05 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.